Detalhe da pesquisa
1.
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.
Cell
; 173(7): 1770-1782.e14, 2018 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29906450
2.
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing.
Cell
; 174(2): 433-447.e19, 2018 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29909985
3.
A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.
Cell
; 154(5): 1074-1084, 2013 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-23993097
4.
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer.
J Pathol
; 262(1): 105-120, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850574
5.
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer.
Prostate
; 84(1): 100-110, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796107
6.
Defining the challenges and opportunities for using patient-derived models in prostate cancer research.
Prostate
; 84(7): 623-635, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450798
7.
Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancer.
Proc Natl Acad Sci U S A
; 118(40)2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593636
8.
Clinical, pathologic, and molecular features of amphicrine prostate cancer.
Prostate
; 83(7): 641-648, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779357
9.
Third generation quinoline-3-carboxamide transcriptional disrupter of HDAC4, HIF-1α, and MEF-2 signaling for metastatic castration-resistant prostate cancer.
Prostate
; 83(15): 1470-1493, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37559436
10.
EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis.
EMBO J
; 38(5)2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723117
11.
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.
Mod Pathol
; 36(10): 100241, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343766
12.
Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.
J Urol
; 209(2): 354-363, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621991
13.
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.
J Pathol
; 257(3): 274-284, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220606
14.
Paracrine Wnt signaling is necessary for prostate epithelial proliferation.
Prostate
; 82(5): 517-530, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35014711
15.
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.
Cancer
; 128(2): 269-274, 2022 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516660
16.
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.
Mod Pathol
; 35(8): 1092-1100, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145197
17.
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort.
J Urol
; 207(4): 805-813, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34854745
18.
Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer.
J Pathol
; 255(4): 425-437, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34431104
19.
Genomic correlates of clinical outcome in advanced prostate cancer.
Proc Natl Acad Sci U S A
; 116(23): 11428-11436, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31061129
20.
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.
Prostate
; 81(16): 1382-1389, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516663